BusinessSummit Highlights Discovery of a Series of New Mechanism Antibiotics for the Treatment of Gonorrhoea in Late-Breaking Presentation at ECCMID 2018By Nasdaq OMXApr 23, 2018, 11:00 AM UTC
BusinessSummit Therapeutics Provides Notice of Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2018By Nasdaq OMXApr 9, 2018, 2:01 PM UTC
BusinessStefanini Exhibits its Digital Solutions for the Retail Industry at NG Retail Summit in FloridaBy Nasdaq OMXApr 3, 2018, 1:59 PM UTC
BusinessSummit’s Infectious Diseases Technology Platform Yields Novel Antibiotics with Potential in Global Fight Against GonorrhoeaBy Nasdaq OMXMar 13, 2018, 11:01 AM UTC
BusinessGrand Rounds Announces Launch of Grand Rounds Summit™, A Comprehensive Clinical Navigation and Network Optimization SolutionBy Nasdaq OMXMar 8, 2018, 3:00 PM UTC
BusinessSummit Announces New Analysis Showing Ezutromid Significantly Reduced Muscle Inflammation in Phase 2 Clinical Trial in DMDBy Nasdaq OMXFeb 26, 2018, 12:00 PM UTC
BusinessSummit Therapeutics Reports Financial Results for the Third Quarter and Nine Months Ended 31 October 2017 and Operational ProgressBy Nasdaq OMXDec 6, 2017, 12:00 PM UTC
BusinessKickStart Europe 2018: Launch of a New Annual European Strategy and Networking SummitBy Nasdaq OMXDec 5, 2017, 7:00 AM UTC
